Targeting PI3K/AKT signaling for treatment of idiopathic pulmonary fibrosis
Idiopathic pulmonary fibrosis (IPF) is a chronic progressive fibrotic interstitial pneumonia with unknown causes. The incidence rate increases year by year and the prognosis is poor without cure. Recently, phosphatidylinositol 3-kinase (PI3K)/protein kinase B (PKB/AKT) signaling pathway can be consi...
Saved in:
Main Authors: | Jincheng Wang (Author), Kaili Hu (Author), Xuanyan Cai (Author), Bo Yang (Author), Qiaojun He (Author), Jiajia Wang (Author), Qinjie Weng (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New Insights of CCR7 Signaling in Dendritic Cell Migration and Inflammatory Diseases
by: Wenxiang Hong, et al.
Published: (2022) -
Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis
by: Jiaying Wang, et al.
Published: (2019) -
Progression of the PI3K/Akt signaling pathway in chronic obstructive pulmonary disease
by: Yanhui Liu, et al.
Published: (2023) -
Dec1 Deficiency Ameliorates Pulmonary Fibrosis Through the PI3K/AKT/GSK-3β/β-Catenin Integrated Signaling Pathway
by: Xingxing Hu, et al.
Published: (2022) -
Challenges and Improvements of Novel Therapies for Ischemic Stroke
by: Lijun Yang, et al.
Published: (2021)